Oncology

The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
How biologics have changed clinical practice over conventional chemotherapies and currently available biosimilars in the US.
[[thumbnail_alt_text]]
Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.
[[thumbnail_alt_text]]
Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.
[[thumbnail_alt_text]]
Researchers examine how stem cells promote neuronal growth in tissue regeneration and in cancer progression.
[[thumbnail_alt_text]]
The researchers plan to present updated data at the European Society for Medical Oncology Breast Cancer conference in May.
[[thumbnail_alt_text]]
Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.
[[thumbnail_alt_text]]
A highlighted session from the ASHP 54th Midyear Clinical Meeting, held December 8-12, 2019, in Las Vegas, Nevada.
[[thumbnail_alt_text]]
New information from the IQVIA “Global Medicine Spending and Usage Trends” report highlights the expected growth of specialty pharmacy spending by 2024.
[[thumbnail_alt_text]]
DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.
[[thumbnail_alt_text]]
New research has examined the details surrounding the signaling molecule interleukin-2, which could lead to more targeted therapies for diseases such as cancer.
[[thumbnail_alt_text]]
Guidelines recommend that Ashkenazi Jewish women discuss genetic testing with physicians, but other women with breast cancer are less likely to receive a recommendation of testing.
[[thumbnail_alt_text]]
A study published in Clinical Cancer Research has shown that using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC) can predict tumor sensitivity to 3 systematic cancer therapies by using artificial intelligence (AI).